Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Rhenman & Partners Asset Management AB 13F Holdings -- Portfolio & Top Positions (2026-03-31)

Rhenman & Partners Asset Management AB (CIK 1599882) reported $810.5M across 86 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: BSX ($39.2M, 4.84%), REGN ($37.2M, 4.59%), LLY ($31.0M, 3.83%), INSM ($26.1M, 3.22%), CVS ($24.2M, 2.98%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1BSXBOSTON SCIENTIFIC CORP$39.2M4.84%625,000Added
2REGNREGENERON PHARMACEUTICALS$37.2M4.59%48,100Trimmed
3LLYLILLY ELI & CO$31.0M3.83%33,715Trimmed
4INSMINSMED INC$26.1M3.22%159,760Added
5CVSCVS HEALTH CORP$24.2M2.98%336,500Added
6GILDGILEAD SCIENCES INC$23.4M2.88%167,750Added
7TMOTHERMO FISHER SCIENTIFIC INC$20.3M2.51%41,340Added
8BIIBBIOGEN INC$20.0M2.47%109,100Added
9VRTXVERTEX PHARMACEUTICALS INC$19.4M2.40%43,485Added
10ALHCALIGNMENT HEALTHCARE INC$18.6M2.29%1.1MAdded
11ISRGINTUITIVE SURGICAL INC$17.0M2.10%36,846Trimmed
12ABCCENCORA INC$16.5M2.03%52,375Trimmed
13SYKSTRYKER CORPORATION$15.7M1.94%47,800New
14ABBVABBVIE INC$15.6M1.92%71,575Trimmed
15VEEVVEEVA SYS INC$15.0M1.85%85,300New
16MCKMCKESSON CORP$14.6M1.80%16,850Trimmed
17JAZZJAZZ PHARMACEUTICALS PLC$14.3M1.77%75,890Added
18GHGUARDANT HEALTH INC$13.4M1.65%145,000Added
19NBIXNEUROCRINE BIOSCIENCES INC$13.3M1.64%100,841Trimmed
20EWEDWARDS LIFESCIENCES CORP$13.1M1.61%163,000Trimmed
21MDGLMADRIGAL PHARMACEUTICALS INC$12.6M1.55%24,050Added
22UNHUNITED HEALTH GROUP INC$12.3M1.52%45,500Trimmed
23PRCTPROCEPT BIOROBOTICS CORP$11.9M1.47%475,000Trimmed
24BMRNBIOMARIN PHARMACEUTICAL INC$11.7M1.44%207,000Trimmed
25ABTABBOTT LABORATORIES$11.5M1.42%112,000New

Source: SEC Form 13F filings · as of 2026-03-31